Article feature image

Recro Pharma, Inc. (REPH) CEO David Enloe on Q2 2021 Results – Earnings Call Transcript

Stock Analysis

Recro Pharma, Inc. (REPH) Q2 2021 Earnings Conference Call August 9, 2021 4:30 PM ET
Company Participants
Stephanie Diaz – IR
David Enloe – President, CEO & Director
Ryan Lake – CFO
Conference Call Participants
Matthew Hewitt – Craig-Hallum Capital Group
…

Click here to view the original article.

Tags:
,
Facebook Google+ Twitter Pinterest

Related Posts